Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (2): 307-311    DOI: 10.31083/j.ceog.2021.02.2294
Original Research Previous articles | Next articles
Change in uterine artery blood flow with intrauterine balloon tamponade
Ryuichi Shimaoka1, *(), Tomomi Shiga1, Ken-ichirou Morishige1
1Department of Obstetrics & Gynecology, Gifu University Graduate School of Medicine, 1-1 Yanagido, 500-0000 Gifu City, Gifu, Japan
Download:  PDF(312KB)  ( 107 ) Full text   ( 8 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
The purpose of this study was to investigate the change in uterine artery blood flow in cases of intrauterine balloon tamponade (IBT). This was a retrospective cross-sectional study of 132 patients who underwent singleton cesarean section. IBT was performed in 35 of the 132 patients. There were 21 cases of placental mediated pregnancy complications (PMPC), which were not included in the IBT group. Placental positional abnormalities were significantly more common in the IBT group than in the control group (89% vs. 9%, P < 0.001). Multivariate analysis identified PMPC as a factor affecting the immediate preoperative uterine artery pulsatility index (UtA-PI). Finally, PMPC was excluded and we assessed 35 and 76 patients assigned to the IBT and control groups, respectively. We compared changes in uterine artery blood flow with and without IBT and by balloon volume. In the IBT group, the immediate pre- and postoperative UtA-PIs were significantly lower (0.56 ± 0.18 vs. 0.63 ± 0.15, P = 0.011, statistical power = 0.577) and higher (1.37 ± 0.66 vs. 0.96 ± 0.28, P < 0.001, statistical power = 0.986), respectively, than those in the control group. The immediate postoperative UtA-PIs depending on balloon expansion volume were 1.13 ± 0.60, 1.24 ± 0.57, and 1.71 ± 0.75, with balloon volumes of 100–199 mL, 200–299 mL, and 300–399 mL, respectively. In summary, IBT during cesarean section increases the immediate post-operative UtA-PI, and tends to increase with increase in balloon volume.
Key words:  Balloon tamponade      Uterine artery      Doppler ultrasound      Cesarean section      Placenta previa     
Submitted:  15 September 2020      Revised:  23 October 2020      Accepted:  28 October 2020      Published:  15 April 2021     
*Corresponding Author(s):  Ryuichi Shimaoka     E-mail:  ryuichi.shimaoka.official@gmail.com

Cite this article: 

Ryuichi Shimaoka, Tomomi Shiga, Ken-ichirou Morishige. Change in uterine artery blood flow with intrauterine balloon tamponade. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 307-311.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.02.2294     OR     https://ceog.imrpress.com/EN/Y2021/V48/I2/307

[1] Jun Xiong, Fen Fu, Wei Zhang, Ji Luo, Yuan-Yuan Xu, Lu-Lu Le, Xiao-Ju He. Study on influencing factors and related clinical issues in cesarean scar pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 365-371.
[2] Ja Young Kim, Yun Gyu Song, Chang-Woon Kim, Moon Ok Lee. Uterine artery embolization using gelatin sponge particles for symptomatic focal and diffuse adenomyosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 59-65.
[3] Bara'a Samara, Anton R. Sabella. The knowledge and attitudes of Palestinian women towards different childbirth delivery options[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 138-143.
[4] Duygu Adıyaman, Bahar Konuralp Atakul, Melda Kuyucu, Hakan Gölbasi, Atalay Ekin. Difference between near-field and far-field of middle cerebral artery doppler pulsatility index and peak systolic velocity: a prospective study[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 66-72.
[5] Jing Wang, Min Zhou, Li Zhang, Long-Xin Zhang. Effective doses 50% and 95% of subarachnoid injection of sufentanil with ropivacaine in lumbar anesthesia for cesarean section in severe preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 105-109.
[6] J.R. Huang, X. Li, C. Fu, Y.H. Deng, T. Gao, H.W. Zhang. Is preprocessing helpful for suction and curettage in treating cesarean scar pregnancy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 900-905.
[7] N.K. Aref. Rectal misoprostol after cesarean delivery: does it affect recovery of bowel functions? A prospective randomized trial[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 906-910.
[8] W.Q. Li, X.S. Deng, G.B. Li, Y.G. Kang. Feasibility of a three-dimensional rotational angiography road map for individualized guidance of uterine artery catheterization[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 687-692.
[9] H. Takahashi, Y. Baba, R. Usui, S. Nagayama, K. Horie, A. Ohkuchi, S. Matsubara. Proteinuria as a novel risk factor for allogeneic blood transfusion irrespective of single or twin pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 709-713.
[10] J.Y. Yan, P.P. Chen, L.L. Jiang, H.L. Zhang, Q. Han, R.X. Chen, Q.J. Zhang. Exploration on the relationship between hypoxia inducible factor-1α and morbidly adherent placenta[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 565-570.
[11] Y. Wang, X.Y. Lu, F. Xu, H.M. Huang, Y. Xu, X.W. Xi. Detection of uterine artery hemodynamic changes in patients with gestational hypertension based on Doppler ultrasonography[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 584-589.
[12] A.M. Sindiani, H.M. Rawashdeh, E.H. Alshdaifat, O.F. Altal, H. Yaseen, A.A. Alhowary. The association between repeated doses of vaginal PGE2 (Dinoprostone, Prostin®) and both maternal and neonatal outcomes among women in the north of Jordan[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 329-334.
[13] J. Huang, Z. Zhang. Spontaneous umbilical cord vascular rupture before labor for congenital defects with a live birth: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 142-143.
[14] K. Relakis, A. Pontikaki, I. Kosmas, S. Sifakis. Bilateral ascending uterine arteries ligation for conservative management of complete placenta previa: three case reports[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 144-146.
[15] H. Takahashi, Y. Baba, M. Ogoyama, H. Suzuki, A. Ohkuchi, R. Usui, S Matsubara. Does previous cesarean section per se, especially its number, increase the risk of allogeneic blood transfusion at cesarean section for placenta previa?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 41-46.
[1] Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31 -46 .
[2] Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9 -21 .
[3] Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38 -46 .
[4] Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49 -55 .
[5] Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175 -181 .
[6] Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16 -21 .
[7] Dean J. Kereiakes. Coronary Small-Vessel Stenting in the Era of Drug Elution[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 34 -45 .
[8] Steven V. Edelman. The Role of the Thiazolidinediones in the Practical Management of Patients With Type 2 Diabetes and Cardiovascular Risk Factors[J]. Reviews in Cardiovascular Medicine, 2003, 4(S6): 29 -37 .
[9] M. Pakiž, L. Lukman, N. Kozar. Patients' and physicians' expectations differ significantly during the follow-up period after completion of primary treatment of gynecological or breast cancer[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 781 -786 .
[10] T. Tomimatsu, S. Mabuchi, T. Tsuboyama, Y. Hori, S. Sekine, T. Kimura. Malignant transformation of uterine leiomyoma: suggested by clinical, imaging, histological, and genetic findings[J]. European Journal of Gynaecological Oncology, 2019, 40(5): 879 -882 .